
Moxifloxacin (0.5% w/v) + Tobramycin (0.3% w/v)
Active composition
+1 more active ingredient
Moxifloxacin inhibits DNA gyrase and topoisomerase IV, disrupting bacterial DNA replication and transcription.
Tobramycin binds to the 30S ribosomal subunit of bacteria, inhibiting protein synthesis and leading to bacterial cell death.
Medical applications
Navimox T Eye Drop is a combined antibacterial ophthalmic solution containing Tobramycin 0.3% w/v and Moxifloxacin 0.5% w/v. This medication is indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of various gram-positive and gram-negative organisms. It provides broad-spectrum activity against common ocular pathogens, helping to reduce bacterial inflammation and promote healing. The use of Navimox T Eye Drop aids in managing symptoms such as redness, discharge, and irritation. The simultaneous presence of two active ingredients enhances therapeutic efficacy and minimizes the risk of bacterial resistance. As with any medication, proper usage and any potential adverse effects should be discussed with a healthcare professional.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Information regarding the use of Navimox T Eye Drop during pregnancy is not available. Please consult your doctor.
High Risk
Information regarding the use of Navimox T Eye Drop during breastfeeding is not available. Please consult your doctor.
Medical Advice
No interaction found/established
Exercise Caution
Navimox T Eye Drop may cause blurring of your vision for a short time just after its use. Do not drive until your vision is clear.
Consult Doctor
No interaction found/established
Regular Checkup
0 reviews for Navimox T Eye Drop

Tobramycin (0.3% w/v) + Moxifloxacin (0.5% w/v)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
+1 more active ingredient
Moxifloxacin inhibits DNA gyrase and topoisomerase IV, disrupting bacterial DNA replication and transcription.
Tobramycin binds to the 30S ribosomal subunit of bacteria, inhibiting protein synthesis and leading to bacterial cell death.
Medical applications
Navimox T Eye Drop is a combined antibacterial ophthalmic solution containing Tobramycin 0.3% w/v and Moxifloxacin 0.5% w/v. This medication is indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of various gram-positive and gram-negative organisms. It provides broad-spectrum activity against common ocular pathogens, helping to reduce bacterial inflammation and promote healing. The use of Navimox T Eye Drop aids in managing symptoms such as redness, discharge, and irritation. The simultaneous presence of two active ingredients enhances therapeutic efficacy and minimizes the risk of bacterial resistance. As with any medication, proper usage and any potential adverse effects should be discussed with a healthcare professional.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Information regarding the use of Navimox T Eye Drop during pregnancy is not available. Please consult your doctor.
High Risk
Information regarding the use of Navimox T Eye Drop during breastfeeding is not available. Please consult your doctor.
Medical Advice
No interaction found/established
Exercise Caution
Navimox T Eye Drop may cause blurring of your vision for a short time just after its use. Do not drive until your vision is clear.
Consult Doctor
No interaction found/established
Regular Checkup
0 reviews for Navimox T Eye Drop















